Literature DB >> 23465341

Outcomes among 3.5 million newly diagnosed hypertensive Canadians.

Hude Quan1, Guanmin Chen, Karen Tu, Gillian Bartlett, Debra A Butt, Norm R C Campbell, Brenda R Hemmelgarn, Michael D Hill, Helen Johansen, Nadia Khan, Lisa M Lix, Mark Smith, Larry Svenson, Robin L Walker, Andy Wielgosz, Finlay A McAlister.   

Abstract

BACKGROUND: This population-based study assessed rates of all-cause mortality, myocardial infarction, heart failure, and stroke for up to 12 years of follow-up in 3.5 million Canadian adults newly diagnosed with hypertension.
METHODS: Hypertension cohort, outcomes, and covariates were defined using validated case definitions applied to inpatient and outpatient administrative health databases. Factors associated with each outcome were identified using Cox proportional hazards models.
RESULTS: Of 3,531,089 adults newly diagnosed with hypertension and without a previous history of cardiovascular disease, 29.4% were younger than 50 years of age; 48.2% were male, and 17.2% resided in a rural area. Over a median follow-up length of 6.1 years, the crude all-cause mortality rate was 22.4 per 1000 person-years. The incidence of hospitalized myocardial infarction (8.4 per 1000 person-years) and hospitalized heart failure (8.5 per 1000 person-years) was higher than stroke (6.9 per 1000 person-years). The incidence rate for any cardiovascular hospitalization was 19.3 per 1000 person-years. Older age, male sex, lower income, rural residence, and a higher number of Charlson comorbidities were each independently associated with a higher risk of mortality and incident cardiovascular disease hospitalizations.
CONCLUSIONS: In a nationally-representative incident cohort of hypertensive adults we have demonstrated higher mortality rates and poorer outcomes for the elderly, males, and those living in rural or low income locations. Innovative approaches to the provision of care for these high-risk individuals will lead to improved patient outcomes.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23465341     DOI: 10.1016/j.cjca.2012.12.016

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Refining hypertension surveillance to account for potentially misclassified cases.

Authors:  Mingkai Peng; Guanmin Chen; Lisa M Lix; Finlay A McAlister; Karen Tu; Norm R Campbell; Brenda R Hemmelgarn; Lawrence W Svenson; Hude Quan
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

2.  Influence of Using Different Databases and 'Look Back' Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers.

Authors:  Guanmin Chen; Lisa Lix; Karen Tu; Brenda R Hemmelgarn; Norm R C Campbell; Finlay A McAlister; Hude Quan
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

3.  Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.

Authors:  Peter Rymkiewicz; Pietro Ravani; Brenda R Hemmelgarn; Finlay A McAlister; Danielle A Southern; Robin Walker; Guanmin Chen; Hude Quan
Journal:  BMC Health Serv Res       Date:  2016-11-22       Impact factor: 2.655

Review 4.  Socioeconomic inequalities in hospitalizations for chronic ambulatory care sensitive conditions: a systematic review of peer-reviewed literature, 1990-2018.

Authors:  Lauren E Wallar; Eric De Prophetis; Laura C Rosella
Journal:  Int J Equity Health       Date:  2020-05-04

5.  Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.

Authors:  Steven M Smith; Tianyao Huo; B Delia Johnson; Vera Bittner; Sheryl F Kelsey; Diane Vido Thompson; C Noel Bairey Merz; Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Am Heart Assoc       Date:  2014-02-28       Impact factor: 5.501

6.  Prevalence and factors associated with hypertension among adults in rural Sylhet district of Bangladesh: a cross-sectional study.

Authors:  Rasheda Khanam; Salahuddin Ahmed; Sayedur Rahman; Gulam Muhammed Al Kibria; Jafar Raza Rizvi Syed; Ahad Mahmud Khan; Syed Mamun Ibne Moin; Malathi Ram; Dustin G Gibson; George Pariyo; Abdullah H Baqui
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

7.  Higher hypertension prevalence, lower incidence, and aggressive treatment with decreasing mortality, cardiovascular, and cerebrovascular incidence in Taiwan from 2005 to 2010: A 2 population-based cohorts study.

Authors:  Chia-Te Liao; Pei-Chih Wu; Jung-Chang Shih; Tain-Junn Cheng; Wen-Shiann Wu
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.